New study shows Canadians don't do enough to protect themselves from melanoma
TORONTO, May 4, 2015 /CNW/ - Today La Roche-Posay launched "Skinchecker," a new international awareness campaign, commended by the Canadian Dermatology Association (CDA) which urges people to check their moles, and aims to educate people on their active role in the early detection of skin cancer.
According to the CDA, skin cancer is the only type of cancer visible to the naked eye, and if diagnosed early, 90 per cent of melanoma cases can be treated effectively.
Since 2000, the incidence of melanoma has increased 75 per cent in Canada vs. 31 per cent for all types of cancer. This year, one out of every three cancers diagnosed in Canada will be skin cancer. It's an alarmingly high number, especially considering Canadians get far fewer mole checks than the rest of the world.1
"As a longstanding partner of dermatologists, dermatological research and all those who suffer from sensitive skin issues, La Roche-Posay believes this campaign will help save lives here in Canada and around the world," said Josee Bordeleau, Medical Relations Lead, La Roche-Posay.
According to a new Ipsos survey carried out for La Roche-Posay in 23 countries across the globe, Canadians rank amongst the lowest with only 32 per cent ever having had a mole check; almost half the international average of 55 per cent. Not surprisingly, Canadians also ranked at the bottom in annual check-ups, with only 6 per cent of the population getting yearly mole checks. Far behind the populations of Germany (24 per cent), Austria (23 per cent) and Italy (20 per cent).
In addition, only 56 per cent of Canadians admitted to wearing sun protection when out in the sun (Ireland, Italy and Portugal came out on top with 69% of their respective populations applying sunscreen), and only one in five Canadians protect themselves year round using sunscreen; Greece (34 percent), Chile (33 per cent) and Australia (32 per cent) led the pack.
To launch Melanoma Awareness Month, La Roche-Posay will be providing free mole checks on Melanoma Monday (May 4, 2015) in Toronto and in Vancouver during the World Dermatology Conference June 9 – 11, 2015.
La Roche-Posay, a leading dermocosmetic brand recommended by 25,000 dermatologists across the world, is the developer of Skincheckers that helps people quickly identify a potential problem and encourages them to go see a dermatologist as soon as possible. Skincheckers is widely promoted by dermatologists across the globe. The new Skinchecker campaign is designed to make everything as easy as possible: one click to download the ABCDE method, and one click to share it with a friend or loved one.
Fewer than one in three (28 per cent) Canadians have ever recommended their loved ones to and get their moles checked, numbers which pale in comparison to the people of Italy (66 per cent), Portugal (63 per cent) and Austria (59 per cent). Furthermore, only 32 per cent of Canadians have ever completed a self-mole check, and just over a quarter of us (27 per cent) complete one yearly. The people of Greece, Australia and Austria self-check most frequently, with 52%, 48% and 45% respectively.
ABOUT LA ROCHE-POSAY
La Roche-Posay is a division of L'Oréal Canada, a wholly-owned subsidiary of L'Oréal Group, the largest cosmetics company in the world. Headquartered in Montreal, L'Oréal Canada had sales of $1.07 billion in 2014 and employs more than 1,200 people. The company's prestigious portfolio of 35 brands encompasses all aspects of beauty.
Through the La Roche-Posay Foundation, under the aegis of the Fondation de France, the brand has been actively supporting research in the clinical, biological and pharmacological fields of dermatology as well as supporting and encouraging generous initiatives from dermatologists.
ABOUT THE CANADIAN DERMATOLOGY ASSOCIATION
The Canadian Dermatology Association, founded in 1925, represents Canadian dermatologists. The association exists to advance the science and art of medicine and surgery related to the care of the skin, hair and nails; provide continuing professional development for its members; support and advance patient care; provide public education on sun protection and other aspects of skin health; and promote a lifetime of healthier skin, hair and nails.
ABOUT IPSOS
Ipsos is an independent market research company controlled and managed by research professionals. Founded in France in 1975, Ipsos has grown into a worldwide research group with a strong presence in all key markets. Ipsos ranks third in the global research industry.
With offices in 87 countries, Ipsos delivers insightful expertise across six research specializations: advertising, customer loyalty, marketing, media, public affairs research, and survey management.
STUDY METHODOLOGY
This survey was carried out by Ipsos for La Roche Posay in 23 countries across the world (Australia, Austria, Belgium, Brazil, Canada, Chile, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Mexico, Norway, Poland, Portugal, Russia, Spain, Sweden, Switzerland, UK, USA). In each of the countries surveyed, 500 to 1000 people (women and men) were interviewed (samples representative of each national population aged 15-65). In total, 19,569 people were interviewed from December 3, 2014 to January 8, 2015.
The interviews were conducted online, except for Russia (face to face interviews), Brazil, Greece and Mexico (telephone interviews).
1 Canadian Cancer Society, Statistics Canada, 2000 & 2014 http://www.cancer.ca/en/cancer-information/cancer-101/canadian-cancer-statistics-publication/?region=on
SOURCE La Roche-Posay
Image with caption: "Melanoma Awareness Month event hits Toronto with consumer activation to become a #skinchecker (CNW Group/La Roche-Posay)". Image available at: http://photos.newswire.ca/images/download/20150504_C7719_PHOTO_EN_16096.jpg
MEDIA CONTACTS: Richelle Robillard, High Road, [email protected], 647-383-8857
Share this article